Vol.46, No.1, Jun. 2018
Actual status and future perspective of clinical trial data sharing-Ethics, credibility, and available technology for trial data linkage- /
The past, present and future of bioethics and research ethics (Part VI)
|
Contents |
|
●Editorial | Tsubaki H | 5-6 | | Full text |
|
●Actual status and future perspective of clinical trial data sharing
-Ethics, credibility, and available technology for trial data linkage- | | | | |
Round table discussion:Actual status and future perspective of clinical trial data sharing
-Ethics, credibility, and available technology for trial data linkage- | Yamauchi K,Tsumoto S,Tsubaki H,et al. (Organized by:Kurihara C) | 7-42 | | Abstract |
|
●Articles | | | | |
Considering the future of clinical research at the turning point of implementation of the new legislation in Japan -Forthcoming enforcement of the Clinical Research Act- | Ohshima H,Aoyagi M,Tajima M,et al. | 43-50 | | Full text |
Clinical evaluation of mindfulness practices: A review of the literature | Saio T | 51-69 | | Full text |
|
●Translation; commentary and annotations | | | | |
OECD Guidelines for the testing of chemicals Fish, early-life stage toxicity
test
Statistical guidance for NOEC determination TG 210, ANNEX 5 | Organisation for Economic Co-operation and Development (OECD) (Trans. by Matsumoto K,Matsuda S) | 71-6 | | |
Commentary and annotations for the OECD Guidelines for the testing of chemicals TG 210, ANNEX 5 | Matsumoto K,Matsuda S | 77-82 | | Abstract |
|
●Original | | | | |
Possibility for improvement in Namibian health and drug development: eHealth security for fingerprint authentication | Imamura O,Matsi F,Kaulihowa T,et al. | 83-90 | | Full text |
|
●The past, present and future of bioethics and research ethics (Part VI) | | | | |
Interview with Dr. Yoshitake Yokokura, President, World Medical Association
-Perspectives toward the world collaboration
for Universal Health Coverage, One Health, and disaster medicine- | Yokokura Y (Interviewed by Kurihara C) | 91-6 | | Full text |
WMA DECLARATION OF TAIPEI ON ETHICAL CONSIDERATIONS REGARDING HEALTH DATABASES AND BIOBANKS | World Medical Association Inc. (Trans. by Japan Medical Association) | 97-106 | | |
Interview with Dr. Ketan Desai, President of the World Medical Association 2016-2017, and Dr. Ajay Kumar, Indian Medical Association: Rise in status of WMA as the world health force; professional autonomy of Indian doctors | Desai K,Kumar A (Interview and trans. by Kurihara C,Saio T) | 107-11 | | Full text |
Interview with Dr. Jon Snaedal, Chair of the World Medical Association Workgroup for the Taipei Declaration; Representative of the Icelandic Medical Association: Health databases, biobank and fundamental human rights | Snaedal J (Interview and trans. by Kurihara C,Saio T) | 113-8 | | Full text |
Interview with Prof. Dr. Elmar Doppelfeld on the significance of the Recommendation of the Council of Europe on research on biological materials of human origin: Comments on the WMA Taipei Declaration and legal protection of the rights of a donner of biological material | Doppelfeld E (Interview and trans. by Kurihara C,Saio T) | 119-26 | | Full text |
Recommendation CM/Rec(2016)6 of the Committee of Ministers to member States on research on biological materials of human origin | Council of Europe (Trans. by Kurihara C,Saio T) | 127-34 | | |
The World Medical Association General Assembly in Taipei 2016 and their activities before and after that: Declaration of Taipei; Declaration of Geneva; and the 50th anniversary of the Declaration of Helsinki | Kurihara C,Saio T | 135-45 | | Full text |
|
●Instructions for authors[Japanese] & [English] | |
147-55 |
|
Full text |
|
●Editor's note | Kurihara M | 157 | | Full text |
|
[Electronic publications only] | | | | |
●The past, present and future of bioethics and research ethics (Part VI) | | | | |
Interview with Dr. Ketan Desai, President of the World Medical Association 2016-2017, and Dr. Ajay Kumar, Indian Medical Association: Rise in status of WMA as the world health force; professional autonomy of Indian doctors | Desai K,Kumar A (Interviewed by Kurihara C,Saio T) | 159-63 W9-W13 | | Full text |
Interview with Dr. Jon Snaedal, Chair of the World Medical Association Workgroup for the Taipei Declaration; Representative of the Icelandic Medical Association: Health databases, biobank and fundamental human rights | Snaedal J (Interviewed by Kurihara C,Saio T) | 165-70 W15-W20 | | Full text |
Interview with Prof. Dr. Elmar Doppelfeld on the significance of the Recommendation of the Council of Europe on research on biological materials of human origin: Comments on the WMA Taipei Declaration and legal protection of the rights of a donner of biological material | Doppelfeld E (Interviewed by Kurihara C,Saio T) | 171-8 W21-W28 | | Full text |
The World Medical Association General Assembly in Taipei 2016 and their activities before and after that: Declaration of Taipei; Declaration of Geneva; and the 50th anniversary of the Declaration of Helsinki | Kurihara C,Saio T | 179-90 W29-W40 | | Full text |